AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 41.27 |
Market Cap | 1.96B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.39 |
PE Ratio (ttm) | -108.46 |
Forward PE | n/a |
Analyst | Hold |
Ask | 47.69 |
Volume | 179,877 |
Avg. Volume (20D) | 578,939 |
Open | 42.49 |
Previous Close | 42.32 |
Day's Range | 41.49 - 42.57 |
52-Week Range | 25.12 - 55.75 |
Beta | undefined |
About OMCL
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital,...
Analyst Forecast
According to 6 analyst ratings, the average rating for OMCL stock is "Hold." The 12-month stock price forecast is $47, which is an increase of 11.11% from the latest price.
Next Earnings Release
Analysts project revenue of $287.96M, reflecting a 11.25% YoY growth and earnings per share of 0.47, making a 42.42% increase YoY.